{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T15:58:38Z","timestamp":1712678318563},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,11,11]],"date-time":"2013-11-11T00:00:00Z","timestamp":1384128000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2369-14-248","type":"journal-article","created":{"date-parts":[[2013,11,11]],"date-time":"2013-11-11T19:01:14Z","timestamp":1384196474000},"source":"Crossref","is-referenced-by-count":3,"title":["Varenicline induced acute interstitial nephritis in the setting of idiopathic membranous glomerulonephritis"],"prefix":"10.1186","volume":"14","author":[{"given":"Wilson","family":"Kwong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine A","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,11]]},"reference":[{"key":"669_CR1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.tips.2010.12.008","volume":"32","author":"R Polosa","year":"2011","unstructured":"Polosa R, Benowitz NL: Treatment of nicotine addiction: present therapeutic options and pipeline developments. Trends Pharmacol Sci. 2011, 32: 281-9. 10.1016\/j.tips.2010.12.008.","journal-title":"Trends Pharmacol Sci"},{"key":"669_CR2","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1177\/0091270006291837","volume":"46","author":"AH Burstein","year":"2006","unstructured":"Burstein AH, Fullerton T, Clark DJ, Faessel HM: Pharmacokinetics, safety, and tolerability after single and multiple oral doses of varenicline in elderly smokers. J Clin Pharmacol. 2006, 46: 1234-40. 10.1177\/0091270006291837.","journal-title":"J Clin Pharmacol"},{"key":"669_CR3","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/j.1365-2125.2009.03520.x","volume":"68","author":"P Ravva","year":"2009","unstructured":"Ravva P, Gastonguay MR, Tensfeldt TG, Faessel HM: Population pharmacokinetic analysis of varenicline in adult smokers. Br J Clin Pharmacol. 2009, 68: 669-81. 10.1111\/j.1365-2125.2009.03520.x.","journal-title":"Br J Clin Pharmacol"},{"key":"669_CR4","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1177\/0091270010370461","volume":"51","author":"Q Zhao","year":"2011","unstructured":"Zhao Q, Schwam E, Fullerton T, et al: Pharmacokinetics, safety, and tolerability following multiple oral doses of varenicline under various titration schedules in elderly nonsmokers. J Clin Pharmacol. 2011, 51: 492-501. 10.1177\/0091270010370461.","journal-title":"J Clin Pharmacol"},{"key":"669_CR5","volume-title":"Varenicline tartrate","author":"Pfizer Canada Inc. Product Monograph CHAMPIX","year":"2011","unstructured":"Pfizer Canada Inc. Product Monograph CHAMPIX: Varenicline tartrate. 2011"},{"key":"669_CR6","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1503\/cmaj.110218","volume":"183","author":"S Singh","year":"2011","unstructured":"Singh S, Loke YK, Spangler JG, Furberg CD: Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis. CMAJ. 2011, 183: 1359-66. 10.1503\/cmaj.110218.","journal-title":"CMAJ"},{"key":"669_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/jama.296.1.47","volume":"296","author":"D Gonzales","year":"2006","unstructured":"Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, Reeves KR: Varenicline phase 3 study group: varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA. 2006, 296: 47-55. 10.1001\/jama.296.1.47.","journal-title":"JAMA"},{"key":"669_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1001\/jama.296.1.56","volume":"296","author":"DE Jorenby","year":"2006","unstructured":"Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, Billing CB, Gong J, Reeves KR: Varenicline phase 3 study group: efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA. 2006, 296: 56-63. 10.1001\/jama.296.1.56.","journal-title":"JAMA"},{"key":"669_CR9","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1001\/archinte.166.15.1561","volume":"166","author":"M Nides","year":"2006","unstructured":"Nides M, Oncken C, Gonzales D, Rennard S, Watsky EJ, Anziano R, Reeves KR: Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up. Arch Intern Med. 2006, 166: 1561-8. 10.1001\/archinte.166.15.1561.","journal-title":"Arch Intern Med"},{"key":"669_CR10","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1345\/aph.1L355","volume":"42","author":"ML Bird","year":"2008","unstructured":"Bird ML, Vesta KS: Varenicline-associated acute renal failure. Ann Pharmacother. 2008, 42: 1908-11. 10.1345\/aph.1L355.","journal-title":"Ann Pharmacother"},{"key":"669_CR11","doi-asserted-by":"crossref","unstructured":"Selby MG, Fidler ME, Shields RC, Kashani KB: Does varenicline induce acute interstitial nephritis. Mayo Clin Proc. 84: 560-1.","DOI":"10.4065\/84.6.560"},{"key":"669_CR12","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S0272-6386(00)70196-X","volume":"35","author":"M Haas","year":"2000","unstructured":"Haas M, Spargo BH, Wit EJ, Meehan SM: Etiologies and outcome of acute renal insufficiency in older adults: a renal biopsy study of 259 cases. Am J Kidney Dis. 2000, 35: 433-47. 10.1016\/S0272-6386(00)70196-X.","journal-title":"Am J Kidney Dis"},{"key":"669_CR13","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/ki.2010.89","volume":"77","author":"M Praga","year":"2010","unstructured":"Praga M, Gonzalez E: Acute interstitial nephritis. Kidney Int. 2010, 77: 956-61. 10.1038\/ki.2010.89.","journal-title":"Kidney Int"},{"key":"669_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/ndt\/gfg464","volume":"19","author":"RJ Baker","year":"2004","unstructured":"Baker RJ, Pusey CD: The changing profile of acute tubulointerstitial nephritis. Nephrol Dial Transplant. 2004, 19: 8-11. 10.1093\/ndt\/gfg464.","journal-title":"Nephrol Dial Transplant"},{"key":"669_CR15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nrneph.2010.71","volume":"6","author":"MA Perazella","year":"2010","unstructured":"Perazella MA, Markowitz GS: Drug-induced acute interstitial nephritis. Nat Rev Nephrol. 2010, 6: 461-70. 10.1038\/nrneph.2010.71.","journal-title":"Nat Rev Nephrol"},{"key":"669_CR16","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1046\/j.1523-1755.2001.060002804.x","volume":"60","author":"J Rossert","year":"2001","unstructured":"Rossert J: Drug-induced acute interstitial nephritis. Kidney Int. 2001, 60: 804-17. 10.1046\/j.1523-1755.2001.060002804.x.","journal-title":"Kidney Int"},{"key":"669_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1093\/ndt\/5.2.94","volume":"5","author":"JG Buysen","year":"1990","unstructured":"Buysen JG, Houthoff HJ, Krediet RT, Arisz L: Acute interstitial nephritis: a clinical and morphological study in 27 patients. Nephrol Dial Transplant. 1990, 5: 94-9. 10.1093\/ndt\/5.2.94.","journal-title":"Nephrol Dial Transplant"},{"key":"669_CR18","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/sj.ki.5002776","volume":"73","author":"E Gonzalez","year":"2008","unstructured":"Gonzalez E, Gutierrez E, Galeano C, Chevia C, De Sequera P, Bernis C, Parra EG, Delgado R, Sanz M, Ortiz M, Goicoechea M, Quereda C, Olea T, Bouarich H, Hernandez Y, Segovia B, Praga M, Grupo Madrileno De Nefritis Intersticiales: Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis. Kidney Int. 2008, 73: 940-6. 10.1038\/sj.ki.5002776.","journal-title":"Kidney Int"},{"key":"669_CR19","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1093\/ndt\/gfh485","volume":"19","author":"MR Clarkson","year":"2004","unstructured":"Clarkson MR, Giblin L, O'Connell FP, O'Kelly P, Walshe JJ, Conlon P, O'Meara Y, Dormon A, Campbell E, Donohoe J: Acute interstitial nephritis: clinical features and response to corticosteroid therapy. Nephrol Dial Transplant. 2004, 19: 2778-83. 10.1093\/ndt\/gfh485.","journal-title":"Nephrol Dial Transplant"},{"key":"669_CR20","doi-asserted-by":"publisher","first-page":"718","DOI":"10.2215\/CJN.01711105","volume":"1","author":"DC Preddie","year":"2006","unstructured":"Preddie DC, Markowitz GS, Radhakrishnan J, Nickolas TL, D'Agati VD, Schwimmer JA, Gardenswartz M, Rosen R, Appel GB: Mycophenolate mofetil for the treatment of interstitial nephritis. Clin J Am Soc Nephrol. 2006, 1: 718-22. 10.2215\/CJN.01711105.","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-14-248\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-14-248.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-14-248","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-14-248.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T23:09:37Z","timestamp":1548198577000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-14-248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,11]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["669"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-14-248","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,11]]},"article-number":"248"}}